JACLYN GUARINO: Open Payments
NPI 1659637130 · MC MURRAY, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,929 in 163 payments from 26 companies in 2025. Trend: 2023 $2,433 · 2024 $2,507 · 2025 $2,929
Food & beverage: $2,929
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 45 | $817 |
| Daiichi Sankyo Inc. | 16 | $351 |
| PFIZER INC. | 26 | $298 |
| Novo Nordisk Inc | 17 | $276 |
| GlaxoSmithKline, LLC. | 10 | $200 |
| Abbott Laboratories | 8 | $141 |
| Lilly USA, LLC | 7 | $128 |
| Teva Pharmaceuticals USA, Inc. | 6 | $125 |
| Lundbeck LLC | 3 | $87 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $72 |
Products named: QULIPTA, INJECTAFER, VRAYLAR, UBRELVY, NURTEC ODT, FREESTYLE LIBRE 3, AUSTEDO XR, TRELEGY ELLIPTA.
Industry payments across PA — which companies pay providers there.
